|Bid||0.0860 x 2236300|
|Ask||0.0880 x 971900|
|Day's range||0.0860 - 0.0880|
|52-week range||0.0750 - 0.3050|
|Beta (5Y monthly)||0.50|
|PE ratio (TTM)||N/A|
|Earnings date||28 Apr 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Kelyniam Global (OTC: KLYG), a leading maker of custom cranial implants, today announced results for its quarter ended March 31, 2023.
Osteopore International (ASX:OSX) ("Osteopore", "OSX" or the "Company"), a Singapore- and Australia-based med-tech company focusing on facilitating natural tissue regeneration, is primed for the global limelight after quietly developing and commercialising its novel 3D-printed bioresorbable scaffold implants that have the potential to revolutionise the way surgeons help patients to naturally regrow bones and other tissues.